Navamedic ASA(DE:N1A)
€0.96+0.00 (+0.42%)
DE:N1A
Navamedic ASA financials statements
€0.96
At close:+0.00 (+0.42%)
Navamedic ASA (N1A) Ratios
1 Followers
Navamedic ASA Ratios
DE:N1A's free cash flow for Q3 2026 was kr4.72M. For the 2026 fiscal year, DE:N1A's free cash flow was decreased by kr-433.00K and operating cash flow was kr5.15M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 1.42 | 1.11 | 1.93 | 1.51 |
| Quick Ratio | 0.89 | 0.84 | 0.55 | 1.30 | 1.06 |
| Cash Ratio | 0.42 | 0.26 | 0.20 | 0.43 | 0.38 |
| Solvency Ratio | 0.02 | 0.06 | 0.05 | 0.21 | 0.04 |
| Operating Cash Flow Ratio | 0.15 | 0.27 | 0.01 | 0.14 | -0.01 |
| Short-Term Operating Cash Flow Coverage | 0.56 | 1.08 | 0.03 | 1.32 | -0.13 |
| Net Current Asset Value | kr -135.79M | kr -50.81M | kr -91.80M | kr 70.49M | kr 26.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.28 | 0.33 | 0.16 | 0.17 |
| Debt-to-Equity Ratio | 0.68 | 0.58 | 0.78 | 0.30 | 0.36 |
| Debt-to-Capital Ratio | 0.40 | 0.37 | 0.44 | 0.23 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.29 | 0.31 | 0.17 | 0.20 |
| Financial Leverage Ratio | 2.22 | 2.04 | 2.36 | 1.83 | 2.18 |
| Debt Service Coverage Ratio | 0.66 | 0.82 | 0.36 | 2.42 | 1.05 |
| Interest Coverage Ratio | 1.12 | 1.43 | 1.64 | 14.86 | 1.10 |
| Debt to Market Cap | 0.42 | 0.30 | 0.26 | 0.10 | 0.09 |
| Interest Debt Per Share | 10.09 | 8.87 | 10.84 | 3.93 | 3.63 |
| Net Debt to EBITDA | 3.22 | 2.21 | 3.66 | 0.15 | 0.19 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.42% | 39.30% | 38.88% | 42.79% | 40.13% |
| EBIT Margin | 2.87% | 5.98% | 4.92% | 11.63% | 4.11% |
| EBITDA Margin | 8.42% | 8.76% | 7.25% | 14.20% | 5.99% |
| Operating Profit Margin | 2.87% | 4.54% | 4.61% | 13.28% | 1.75% |
| Pretax Profit Margin | -2.77% | 0.97% | 2.12% | 11.12% | 0.85% |
| Net Profit Margin | -4.16% | 0.24% | 0.65% | 7.70% | 0.22% |
| Continuous Operations Profit Margin | -4.16% | 0.24% | 0.65% | 7.70% | 1.37% |
| Net Income Per EBT | 150.34% | 25.02% | 30.50% | 69.24% | 26.21% |
| EBT Per EBIT | -96.33% | 21.36% | 45.94% | 83.74% | 48.53% |
| Return on Assets (ROA) | -3.17% | 0.26% | 0.63% | 7.69% | 0.19% |
| Return on Equity (ROE) | -7.05% | 0.54% | 1.49% | 14.03% | 0.41% |
| Return on Capital Employed (ROCE) | 2.87% | 6.89% | 7.04% | 19.77% | 2.50% |
| Return on Invested Capital (ROIC) | 2.64% | 1.65% | 1.77% | 12.91% | 0.62% |
| Return on Tangible Assets | -8.31% | 0.54% | 1.22% | 11.70% | 0.26% |
| Earnings Yield | -4.12% | 0.28% | 0.52% | 5.02% | 0.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.87 | 9.51 | 13.46 | 3.88 | 5.22 |
| Payables Turnover | 4.15 | 6.42 | 4.58 | 5.00 | 2.36 |
| Inventory Turnover | 3.23 | 3.94 | 2.97 | 2.74 | 2.69 |
| Fixed Asset Turnover | 91.33 | 60.81 | 52.50 | 53.69 | 33.49 |
| Asset Turnover | 0.76 | 1.08 | 0.98 | 1.00 | 0.84 |
| Working Capital Turnover Ratio | 7.25 | 13.28 | 7.40 | 4.08 | 6.79 |
| Cash Conversion Cycle | 71.55 | 74.18 | 70.16 | 154.01 | 51.04 |
| Days of Sales Outstanding | 46.40 | 38.40 | 27.12 | 94.09 | 69.98 |
| Days of Inventory Outstanding | 113.03 | 92.66 | 122.70 | 132.97 | 135.50 |
| Days of Payables Outstanding | 87.88 | 56.88 | 79.66 | 73.06 | 154.44 |
| Operating Cycle | 159.43 | 131.06 | 149.82 | 227.06 | 205.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.07 | 2.17 | 0.13 | 1.07 | -0.08 |
| Free Cash Flow Per Share | 0.97 | 2.17 | -0.00 | 0.93 | -0.12 |
| Dividend Paid and CapEx Coverage Ratio | 10.75 | 11.54 | 0.99 | 7.97 | -1.79 |
| Capital Expenditure Coverage Ratio | 10.75 | 11.54 | 0.99 | 7.97 | -1.79 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.27 | 0.01 | 0.29 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.07 | 0.00 | 0.05 | -0.00 |
| Free Cash Flow Yield | 4.07% | 8.45% | -0.00% | 2.67% | -0.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.29 | 352.05 | 192.75 | 19.93 | 896.58 |
| Price-to-Sales (P/S) Ratio | 1.01 | 0.85 | 1.24 | 1.53 | 1.99 |
| Price-to-Book (P/B) Ratio | 1.71 | 1.89 | 2.86 | 2.80 | 3.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.60 | 11.84 | -33518.26 | 37.38 | -273.22 |
| Price-to-Operating Cash Flow Ratio | 22.31 | 11.84 | 292.27 | 32.69 | -426.22 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -5.72 | -2.16 | 0.00 | -8.68 |
| Enterprise Value Multiple | 15.21 | 11.96 | 20.83 | 10.96 | 33.40 |
| Enterprise Value | 723.98M | 556.72M | 772.55M | 594.96M | 557.20M |
| EV to EBITDA | 15.21 | 11.96 | 20.83 | 10.96 | 33.40 |
| EV to Sales | 1.28 | 1.05 | 1.51 | 1.56 | 2.00 |
| EV to Free Cash Flow | 31.20 | 14.51 | -40660.57 | 37.92 | -274.75 |
| EV to Operating Cash Flow | 28.30 | 14.51 | 354.54 | 33.16 | -428.62 |
| Tangible Book Value Per Share | -5.19 | -0.63 | -1.84 | 4.67 | 3.86 |
| Shareholders’ Equity Per Share | 13.93 | 13.61 | 12.82 | 12.48 | 9.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.50 | 0.75 | 0.70 | 0.31 | 0.74 |
| Revenue Per Share | 23.57 | 30.08 | 29.51 | 22.74 | 17.09 |
| Net Income Per Share | -0.98 | 0.07 | 0.19 | 1.75 | 0.04 |
| Tax Burden | 1.50 | 0.25 | 0.30 | 0.69 | 0.26 |
| Interest Burden | -0.96 | 0.16 | 0.43 | 0.96 | 0.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.11 | 0.11 | 0.02 | 0.03 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Income Quality | -1.63 | -23.68 | 0.66 | 0.42 | -0.55 |
Currency in NOK
